Athena Mears, OD
Vision Therapy · Greenville, SCNPI 1598427155
Payments from drug & device makers
Across 48 payments — averaging $76.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$845
- Bausch & Lomb Americas Inc.$735
- Sun Pharmaceutical Industries Inc.$353
- Alcon$300
- Sight Sciences, Inc.$245
- Oyster Point Pharma, Inc.$227
- plus $968 from 8 others
What the payments were for
- Travel & lodging$36210%
- Food & beverage$3,19787%
- Entertainment$1143%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 10 | $845 |
| Bausch & Lomb Americas Inc. | 11 | $735 |
| Sun Pharmaceutical Industries Inc. | 3 | $353 |
| Alcon | 6 | $300 |
| Sight Sciences, Inc. | 2 | $245 |
| Oyster Point Pharma, Inc. | 3 | $227 |
| Johnson & Johnson Vision Care, Inc. | 3 | $201 |
| Biotissue Holdings Inc. | 4 | $141 |
| Mallinckrodt Hospital Products Inc. | 1 | $122 |
| Apellis Pharmaceuticals, Inc. | 1 | $122 |
| Dompe US, Inc. | 1 | $122 |
| Amgen | 1 | $120 |
| Optos, Inc. | 1 | $114 |
| Carl Zeiss Meditec USA, Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MiSight Contact Lens$462
- CEQUA$353
- PANORAMIC OPHTHALMOSCOPE$228
- OCT OPHTHALMOSCOPE$228
- TYRVAYA$214
- INFUSE$212
- OMNI(R) SURGICAL SYSTEM (US)$154
- SIMBRINZA$125
- Rhopressa$125
- Rocklatan$125
- INFUSE MULTIFOCAL$122
- ACTHAR$122
- Syfovre$122
- Oxervate$122
- MIEBO$120
- TEPEZZA$120
- NFC-700$114
- MyDay Contact Lens$106
- Acuvue$101
- TOTAL30$101
How this compares
Too few vision therapy providers in South Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 11 | $62 |
Paid to pharmacies, not to this prescriber.
Other vision therapy in Greenville
- Rosalie LeeGreenville$3K
- Leigh PurvisCharleston$2K
- Janet WilsonSpartanburg$2K
- Jamie JohnRock Hill$1K
- Frank ForgnoniPendleton$207
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.